×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Strongbridge Biopharma plc. (SBBP) NASDAQ

$2 - (-)

Market Cap: -

As of 10/05/21 12:00 AM EDT. Market closed.

(SBBP)

Strongbridge Biopharma plc. (SBBP)
NASDAQ

$2
- (-)

Market Cap: -

As of 10/05/21 12:00 AM EDT. Market closed.

Add to Portfolio

Strongbridge Biopharma is a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs. Strongbridge's rare endocrine franchise includes RECORLEV® (levoketoconazole), a cortisol synthesis inhibitor currently being studied in Phase 3 clinical studies for the treatment of endogenous Cushing's ... read more

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Matthew Pauls
Full Time Employees
72
CEO Compensation (Base)
$540,000
CEO Compensation (Total)
$2.65M
URL
Address
900 Northbrook Dr Ste 200, Pennsylvania, Trevose, 19053-8433.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Matthew Pauls
Full Time Employees
72
CEO Compensation (Base)
$540,000
CEO Compensation (Total)
$2.65M
Address
900 Northbrook Dr Ste 200, Pennsylvania, Trevose, 19053-8433.
PRICE CHART FOR STRONGBRIDGE BIOPHARMA PLC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$2.01
Previous Close
$2
Days Range
$1.95 - $2.06
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
67,828,952
Open
$2.01
Previous Close
$2
Days Range
$1.95 - $2.06
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
67,828,952
FINANCIAL STATEMENTS FOR STRONGBRIDGE BIOPHARMA PLC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR STRONGBRIDGE BIOPHARMA PLC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Wilhoit Scott L.Chief Commercial OfficerOct 01, 2021 Option Exercise$2.0627,51556,681109,510Oct 05, 2021, 07:28 PM
LONG STEPHEN JChief Legal OfficerOct 01, 2021 Option Exercise$2.0649,307101,572117,793Oct 05, 2021, 07:28 PM
Kollender Richard SPresident and CFOOct 01, 2021 Option Exercise$2.0664,791133,469234,229Oct 05, 2021, 07:27 PM
Cohen Fredric J.Chief Medical OfficerOct 01, 2021 Option Exercise$2.0651,548106,189160,408Oct 05, 2021, 07:26 PM
Steen MartenDirectorOct 01, 2021 Option Exercise$2.0617,76336,59264,151Oct 05, 2021, 07:26 PM
JOHNSON JOHNChief Executive OfficerOct 01, 2021 Option Exercise$2.06334,868689,828610,092Oct 05, 2021, 07:24 PM
Steineger Hilde HDirectorOct 01, 2021 Option Exercise$2.0617,76336,59264,258Oct 05, 2021, 07:24 PM
SHERMAN JEFFREY WDirectorOct 01, 2021 Option Exercise$2.0617,76336,59264,258Oct 05, 2021, 07:23 PM
Kong GarhengDirectorOct 01, 2021 Option Exercise$2.0617,76336,59263,993Oct 05, 2021, 07:22 PM
GILL DAVID NDirectorOct 01, 2021 Option Exercise$2.0617,76336,59278,058Oct 05, 2021, 07:21 PM
Kollender Richard SPresident and CFOSep 03, 2021 Option Exercise$2.2417,08838,277299,020Sep 08, 2021, 04:42 PM
JOHNSON JOHNChief Executive OfficerJul 02, 2021 Option Exercise$3.0850,867156,670944,960Jul 07, 2021, 05:01 PM
Kong GarhengDirectorMay 14, 2021 Option Exercise$2.3519,20045,12041,756May 17, 2021, 07:27 PM
Steineger Hilde HDirectorMay 14, 2021 Option Exercise$2.3518,94444,51842,021May 17, 2021, 06:33 PM
SHERMAN JEFFREY WDirectorMay 14, 2021 Option Exercise$2.3518,94444,51842,021May 17, 2021, 06:31 PM
JOHNSON JOHNChief Executive OfficerApr 08, 2021 Option Exercise$2.6817,32546,431995,827Apr 09, 2021, 05:13 PM
Wilhoit Scott L.Chief Commercial OfficerFeb 22, 2021 Option Exercise$3.627,12125,778137,025Feb 23, 2021, 05:16 PM
Lutz Robert MatthewChief Financial OfficerFeb 22, 2021 Option Exercise$3.626,97825,260181,333Feb 23, 2021, 05:16 PM
LONG STEPHEN JChief Legal OfficerFeb 22, 2021 Option Exercise$3.627,06225,564167,100Feb 23, 2021, 05:15 PM
Cohen Fredric J.Chief Medical OfficerFeb 22, 2021 Option Exercise$3.626,97825,260211,956Feb 23, 2021, 05:14 PM
GILL DAVID NDirectorSep 24, 2020 Buy$2.138,00017,04074,896Sep 28, 2020, 07:48 AM
CDK ASSOCIATES, L.L.C.10% OwnerSep 17, 2020 Buy$2.251,473,3773,315,0988,054,682Sep 21, 2020, 09:48 PM
CDK ASSOCIATES, L.L.C.10% OwnerSep 18, 2020 Buy$2.206,00013,2008,060,682Sep 21, 2020, 09:48 PM
GILL DAVID NDirectorSep 03, 2020 Option Exercise$3.6123,10483,40566,896Sep 04, 2020, 04:28 PM
Steineger Hilde HDirectorMay 15, 2020 Option Exercise$2.8619,03554,44060,965May 18, 2020, 04:52 PM
Steen MartenDirectorMay 15, 2020 Option Exercise$2.8619,08254,57560,918May 18, 2020, 04:52 PM
SHERMAN JEFFREY WDirectorMay 15, 2020 Option Exercise$2.8619,03554,44060,965May 18, 2020, 04:51 PM
Kong GarhengDirectorMay 15, 2020 Option Exercise$2.8619,04454,46660,956May 18, 2020, 04:51 PM
JOHNSON JOHNExecutive ChairmanMay 15, 2020 Option Exercise$2.8615,34843,895207,152May 18, 2020, 04:51 PM
CDK ASSOCIATES, L.L.C.10% OwnerDec 27, 2018 Buy$3.9818,20072,4346,581,305Dec 28, 2018, 05:39 PM
CDK ASSOCIATES, L.L.C.10% OwnerDec 26, 2018 Buy$4.0031,197124,6986,563,105Dec 28, 2018, 05:39 PM
CDK ASSOCIATES, L.L.C.10% OwnerDec 21, 2018 Buy$3.9590,612357,9906,531,908Dec 21, 2018, 06:16 PM
CDK ASSOCIATES, L.L.C.10% OwnerDec 20, 2018 Buy$4.00146,467585,3856,441,296Dec 21, 2018, 06:16 PM
Cohen Fredric J.Chief Medical OfficerNov 23, 2018 Option Exercise$5.211,7409,06513,434Nov 26, 2018, 04:44 PM
CDK ASSOCIATES, L.L.C.10% OwnerAug 08, 2018 Buy$4.93360,9951,778,5146,294,829Aug 09, 2018, 12:28 PM
CDK ASSOCIATES, L.L.C.10% OwnerJul 30, 2018 Buy$4.6670,000326,4665,933,834Aug 01, 2018, 04:56 PM
CDK ASSOCIATES, L.L.C.10% OwnerJul 27, 2018 Buy$4.73209,300989,1885,863,384Jul 27, 2018, 06:15 PM
CDK ASSOCIATES, L.L.C.10% OwnerJul 26, 2018 Buy$4.9439,800196,7275,654,534Jul 27, 2018, 06:15 PM
CDK ASSOCIATES, L.L.C.10% OwnerJul 24, 2018 Buy$4.92150,000737,2655,614,734Jul 27, 2018, 06:15 PM
Cohen Fredric J.Chief Medical OfficerJun 13, 2018 Option Exercise$6.302,17413,69615,174Jul 25, 2018, 03:37 PM
CDK ASSOCIATES, L.L.C.10% OwnerJul 20, 2018 Buy$4.9721,100104,7955,444,334Jul 23, 2018, 05:33 PM
CDK ASSOCIATES, L.L.C.10% OwnerJul 19, 2018 Buy$4.9814,00069,7475,423,234Jul 23, 2018, 05:33 PM
CDK ASSOCIATES, L.L.C.10% OwnerJul 23, 2018 Buy$4.9520,400100,9805,464,734Jul 23, 2018, 05:33 PM
CDK ASSOCIATES, L.L.C.10% OwnerJul 16, 2018 Buy$4.9711,20055,6295,409,234Jul 18, 2018, 01:55 PM
LONG STEPHEN JChief Legal OfficerFeb 26, 2018 Option Exercise$6.609,05659,77010,662Feb 28, 2018, 02:37 PM
Pauls MatthewPresident & CEOFeb 26, 2018 Option Exercise$6.6017,392114,78722,608Feb 28, 2018, 02:37 PM
Cohen Fredric J.Chief Medical OfficerFeb 26, 2018 Option Exercise$6.605,65237,30317,348Feb 28, 2018, 02:37 PM
DAVIS A BRIANChief Financial OfficerFeb 26, 2018 Option Exercise$6.608,69657,39413,366Feb 28, 2018, 02:37 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Wilhoit Scott L.Chief Commercial Officer10/01/202156,681
LONG STEPHEN JChief Legal Officer10/01/2021101,572
Kollender Richard SPresident and CFO10/01/2021133,469
Cohen Fredric J.Chief Medical Officer10/01/2021106,189
Steen MartenDirector10/01/202136,592
JOHNSON JOHNChief Executive Officer10/01/2021689,828
Steineger Hilde HDirector10/01/202136,592
SHERMAN JEFFREY WDirector10/01/202136,592
Kong GarhengDirector10/01/202136,592
GILL DAVID NDirector10/01/202136,592
Kollender Richard SPresident and CFO09/03/202138,277
JOHNSON JOHNChief Executive Officer07/02/2021156,670
Kong GarhengDirector05/14/202145,120
Steineger Hilde HDirector05/14/202144,518
SHERMAN JEFFREY WDirector05/14/202144,518
JOHNSON JOHNChief Executive Officer04/08/202146,431
Wilhoit Scott L.Chief Commercial Officer02/22/202125,778
Lutz Robert MatthewChief Financial Officer02/22/202125,260
LONG STEPHEN JChief Legal Officer02/22/202125,564
Cohen Fredric J.Chief Medical Officer02/22/202125,260
GILL DAVID NDirector09/24/202017,040
CDK ASSOCIATES, L.L.C.10% Owner09/17/20203,315,098
CDK ASSOCIATES, L.L.C.10% Owner09/18/202013,200
GILL DAVID NDirector09/03/202083,405
Steineger Hilde HDirector05/15/202054,440
Steen MartenDirector05/15/202054,575
SHERMAN JEFFREY WDirector05/15/202054,440
Kong GarhengDirector05/15/202054,466
JOHNSON JOHNExecutive Chairman05/15/202043,895
CDK ASSOCIATES, L.L.C.10% Owner12/27/201872,434
CDK ASSOCIATES, L.L.C.10% Owner12/26/2018124,698
CDK ASSOCIATES, L.L.C.10% Owner12/21/2018357,990
CDK ASSOCIATES, L.L.C.10% Owner12/20/2018585,385
Cohen Fredric J.Chief Medical Officer11/23/20189,065
CDK ASSOCIATES, L.L.C.10% Owner08/08/20181,778,514
CDK ASSOCIATES, L.L.C.10% Owner07/30/2018326,466
CDK ASSOCIATES, L.L.C.10% Owner07/27/2018989,188
CDK ASSOCIATES, L.L.C.10% Owner07/26/2018196,727
CDK ASSOCIATES, L.L.C.10% Owner07/24/2018737,265
Cohen Fredric J.Chief Medical Officer06/13/201813,696
CDK ASSOCIATES, L.L.C.10% Owner07/20/2018104,795
CDK ASSOCIATES, L.L.C.10% Owner07/19/201869,747
CDK ASSOCIATES, L.L.C.10% Owner07/23/2018100,980
CDK ASSOCIATES, L.L.C.10% Owner07/16/201855,629
LONG STEPHEN JChief Legal Officer02/26/201859,770
Pauls MatthewPresident & CEO02/26/2018114,787
Cohen Fredric J.Chief Medical Officer02/26/201837,303
DAVIS A BRIANChief Financial Officer02/26/201857,394
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR STRONGBRIDGE BIOPHARMA PLC
LOADING...